TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line (Thyroid Hormone Receptor alpha Pathway)

TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line (Thyroid Hormone Receptor alpha Pathway)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82633 2 vials - -

3 - 8 business days*

13,163.00€
 
The TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line is a HEK293 cell line expressing firefly... more
Product information "TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line (Thyroid Hormone Receptor alpha Pathway)"
The TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line is a HEK293 cell line expressing firefly luciferase under the control of the GAL4 upstream activation sequence (UAS) with constitutive expression of human thyroid receptor alpha ligand binding domain fused to the DNA binding domain (DBD) of GAL4 (GAL4 DBD). This system allows specific detection of thyroid hormone-induced activation of the thyroid receptor alpha with low cross-reactivity from other nuclear receptors. This cell line has been validated by stimulation with triiodothyronine (T-3).
Keywords: EAR7, THRA, EAR-7, c-erbA-1, c-erbA-alpha, V-erbA-related protein 7, Thyroid hormone receptor alpha, Nuclear receptor subfamily 1 group A member 1,
Supplier: BPS Bioscience
Supplier-Nr: 82633

Properties

Application: TRalpha agonist screening
Species reactivity: human

Handling & Safety

Storage: Liquid nitrogen
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "TRalpha-GAL4 Luciferase Reporter HEK293 Cell Line (Thyroid Hormone Receptor alpha Pathway)"
Write a review
or to review a product.
Viewed